Your browser doesn't support javascript.
loading
Comparison of clinical outcomes of conbercept versus ranibizumab treatment for retinopathy of prematurity: a multicentral prospective randomised controlled trial.
Wu, Zhenquan; Zhao, Jinfeng; Lam, Waiching; Yang, Mingmin; Chen, Lu; Huang, Xuelin; Wei, Meirong; Yang, Hui; Lv, Fan; Zhang, Fuyan; Zeng, Jian; Zhang, Guo-Ming.
  • Wu Z; Ophthalmology, Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Shenzhen University School of Medicine, Shenzhen, Guangdong, China, Shenzhen, Guangdong, China.
  • Zhao J; Ophthalmology, Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Shenzhen University School of Medicine, Shenzhen, Guangdong, China, Shenzhen, Guangdong, China.
  • Lam W; Ophthalmology, The University of Hong Kong, Grantham Hospital, Hong Kong, China.
  • Yang M; Ophthalmology, Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Shenzhen University School of Medicine, Shenzhen, Guangdong, China, Shenzhen, Guangdong, China.
  • Chen L; Ophthalmology, Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Shenzhen University School of Medicine, Shenzhen, Guangdong, China, Shenzhen, Guangdong, China.
  • Huang X; Ophthalmology, Guangdong Provincial Maternity and Children's Hospital, Guangzhou, Guangdong, China.
  • Wei M; Ophthalmology, Liuzhou Maternity and Children's Hospital, Liuzhou, China.
  • Yang H; Ophthalmology, Xiamen Children's Hospital, Xiamen, China.
  • Lv F; Ophthalmology, Quanzhou Children's Hospital, Quanzhou, China.
  • Zhang F; Ophthalmology, Guizhou Medical University, Guiyang, Guizhou, China.
  • Zeng J; Ophthalmology, Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Shenzhen University School of Medicine, Shenzhen, Guangdong, China, Shenzhen, Guangdong, China.
  • Zhang GM; Ophthalmology, Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Shenzhen University School of Medicine, Shenzhen, Guangdong, China, Shenzhen, Guangdong, China 13823509060@163.com.
Br J Ophthalmol ; 106(7): 975-979, 2022 07.
Article en En | MEDLINE | ID: mdl-33637618

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Retinopatía de la Prematuridad / Ranibizumab Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Humans / Infant / Newborn Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Retinopatía de la Prematuridad / Ranibizumab Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Humans / Infant / Newborn Idioma: En Año: 2022 Tipo del documento: Article